Disc Medicine announced it will present new data from several clinical trials at the 68th ASH Annual Meeting in December 2026, including Phase 2 updates on selcodebart for myelofibrosis anemia and DISC-3405 for polycythemia vera, as well as initial Phase 1b data for sickle cell disease. The presentations highlight progress in their pipeline, especially following positive Phase 3 results for bitopertin in erythropoietic protoporphyria. Management plans a conference call post-event to discuss next development steps, signaling ongoing momentum in developing novel therapies for serious hematologic diseases.
Disc Medicine's clinical trial updates are announced ahead of the 68th ASH Annual Meeting. For readers following the health sector, here is Pluang's market snapshot as of Nov 04, 2026 20:41 WIB: out of 150 priced health-sector US stocks, 127 rose and 19 fell today. Notable movers include TLRY at USD 2.78 (+4.91%, Pluang order activity 96% Sell / 4% Buy), ALC at USD 75.51 (+4.34%, Pluang order activity 91% Sell / 9% Buy), and SYRE at USD 95.00 (-4.30%).
Kelly Technology + Motion Recruitment, a division of Kelly Services, has been recognized as a Leader on Everest Group's 2026 U.S. IT Contingent Talent and Strategic Solutions PEAK Matrix® for its expertise in specialized IT staffing, consulting, and ...
Sutro Biopharma, a clinical-stage oncology company specializing in antibody drug conjugates (ADCs), announced its participation in several investor conferences in November and December 2026, including events hosted by Stifel, Truist Securities, UBS, ...
etoro has agreed to acquire LB Finanzas, a leading Argentine all-in-one financial app, to strengthen its presence in Latin America's fast-growing fintech market. LB Finanzas offers integrated investing and payment solutions, catering to Argentine ret...
JD.com announced it will publish its unaudited financial results for the third quarter of 2026 on November 17, before the U.S. market opens. The company's management will hold a conference call the same day to discuss the results, providing investors...
KE Holdings Inc., a major online and offline housing platform in China, will announce its unaudited financial results for the third quarter of 2026 on November 16 before the U.S. market opens. The company will host an earnings conference call at 7:00...
